---
$id: https://graph.org.ai/products/commodity/51131749
$type: Product
source: UNSPSC
code: "51131749"
title: "Lamifiban hydrochloride"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lamifiban hydrochloride

**UNSPSC Code**: 51131749
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent with the molecular formula C24H28N4O6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3UZ1CTQ989, chemically known as (s)-((1-(2-((4-(aminoiminomethyl)benzoyl)amino)-3-(4-hydroxyphenyl)-1-oxopropyl)-4-piperidinyl)oxy)acetic acid monohydrochloride, but more generally known as lamifiban hydrochloride, which bears US NIH Compound Identifier 3038483. European Medicines Agency schedules lamifiban hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08391MIG. Most nations, for tariff purposes, schedule lamifiban hydrochloride under HS 29333999. Lamifiban hydrochloride bears US NLM identifiers UMLS ID C2825685 and NCI Concept Code C81568. SMILES: C1CC(CCC1C[C@@H](C(=O)N2CCC(CC2)OCC(=O)O)NC(=O)C3CCC(CC3)C(=N)N)O.CL.

